Table 3.
Statistic | Baseline (Week 1) | Active | Pct Difference (Active − Baseline) | Sham | Pct Difference (Sham − Baseline) | Difference of Pct Differences (Active − Sham) |
---|---|---|---|---|---|---|
N | 17 | 17 | 17 | 17 | 17 | 17 |
Mean (SD) | 6.9 (1.3) | 3.5 (2.7) | −51.0 (33.7) | 5.8 (2.6) | −15.8 (35.0) | −35.2 (48.2) |
Median | 7.0 | 3.3 | −60.0 | 6.7 | −4.2 | −31.8 |
Min, Max | 4.3, 9.0 | 0.0, 8.3 | −100, 0.0 | 2.0, 9.0 | −72.7, 33.3 | −115, 52.4 |
95% CI | (6.2, 7.6) | (2.1, 4.9) | (−68.3, −33.7) | (4.5, 7.2) | (−33.7, 2.2) | (−60.0, −10.5) |
p-value (paired t-test) | <.0001 | 0.0408 | 0.0041 | |||
p-value (signed-rank test) | <.0001 | 0.0898 | 0.0040 |
All Randomized Patients with Complete Data.
[1] Wilcoxon signed-rank tests were performed to assess percent change from baseline in the OCS score one week after active treatment and sham treatment, separately.
[2] A Wilcoxon signed-rank test was performed to compare the percent change from baseline in the OCS score on active treatment versus sham treatment (Difference of Percent Differences column). A positive value for the difference of percent difference favors sham treatment, while a negative value favors active treatment.
[3] One-sided lower p-values were calculated for all tests.